CRISPR Therapeutics News - CRSP

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
CRISPR Therapeutics AG CRSP NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -1.82 -3.22% 54.75 57.0014 53.90 56.75 56.57 00:00:02
more quote information »

Recent News

Date Time Source Heading
1/24/202016:09EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/10/202016:50EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/06/202016:05GLOBECRISPR Therapeutics to Present at the Goldman Sachs 12th..
12/27/201916:07EDGARCurrent Report Filing (8-k)
12/18/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
12/16/201907:02EDGARCurrent Report Filing (8-k)
12/05/201916:07EDGARStatement of Changes in Beneficial Ownership (4)
12/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
12/05/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
12/05/201916:01EDGARStatement of Changes in Beneficial Ownership (4)
12/02/201917:12EDGARStatement of Changes in Beneficial Ownership (4)
11/27/201907:00GLOBECRISPR Therapeutics to Present at Upcoming Investor..
11/26/201916:32EDGARStatement of Ownership (sc 13g)
11/22/201916:02EDGARCurrent Report Filing (8-k)
11/21/201916:12EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/21/201916:10EDGARStatement of Changes in Beneficial Ownership (4)
11/21/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
11/20/201921:18GLOBECRISPR Therapeutics Announces Pricing of Public Offering of..
11/19/201916:29EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/19/201916:14GLOBECRISPR Therapeutics Announces Proposed Public Offering of..
11/19/201908:22EDGARCurrent Report Filing (8-k)
11/19/201907:00GLOBECRISPR Therapeutics and Vertex Announce Positive Safety and..
11/13/201916:31EDGARStatement of Changes in Beneficial Ownership (4)
11/01/201918:35EDGARStatement of Changes in Beneficial Ownership (4)
11/01/201918:34EDGARStatement of Changes in Beneficial Ownership (4)
10/28/201908:03EDGARQuarterly Report (10-q)
10/28/201907:06EDGARCurrent Report Filing (8-k)
10/28/201907:00GLOBECRISPR Therapeutics Provides Business Update and Reports..
10/15/201907:00GLOBECRISPR Therapeutics and KSQ Therapeutics Announce License..
10/01/201907:00GLOBECRISPR Therapeutics to Present at Upcoming Investor..
9/17/201907:00GLOBECRISPR Therapeutics and ViaCyte Present Positive In Vitro..
9/12/201916:34EDGARStatement of Changes in Beneficial Ownership (4)
9/12/201916:32EDGARStatement of Changes in Beneficial Ownership (4)
9/03/201916:23EDGARStatement of Changes in Beneficial Ownership (4)
8/30/201916:11EDGARCurrent Report Filing (8-k)
8/30/201916:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
8/05/201917:50EDGARStatement of Changes in Beneficial Ownership (4)
7/31/201907:01GLOBECRISPR Therapeutics to Present at Upcoming Investor..
7/29/201916:33EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/29/201916:21EDGARQuarterly Report (10-q)
7/29/201916:06EDGARCurrent Report Filing (8-k)
7/29/201916:01GLOBECRISPR Therapeutics Provides Business Update and Reports..
7/12/201916:14EDGARStatement of Changes in Beneficial Ownership (4)
7/12/201916:11EDGARStatement of Changes in Beneficial Ownership (4)
7/01/201916:01GLOBECRISPR Therapeutics Announces Oral Presentation at the 55th..
6/28/201914:29EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/26/201908:46EDGARCurrent Report Filing (8-k)
6/19/201916:16EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201917:08EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201917:06EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NASDAQ
CRSP
CRISPR The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200126 10:12:10